We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Drugs that made headlines in 2014.
- Authors
Keener, Amanda
- Abstract
The article focuses on several drugs developed or in process of development in 2014. Topics discussed include approval of antibiotic drug Esbriet (pirfenidone) from InterMune, used to treat idiopathic pulmonary fibrosis by the U.S. Food and Drug Administration (FDA), clinical trials on crenezumab as an antibody designed to clear the plaque-forming peptide beta amyloid by Roche Pharmaceuticals Ltd., and failure of darapladib in preventing cardiac events among coronary heart disease patients.
- Subjects
DRUG development; IDIOPATHIC pulmonary fibrosis; INTERMUNE Inc.; ROCHE Pharmaceuticals Ltd.; CORONARY heart disease treatment; DRUG approval; UNITED States. Food &; Drug Administration; THERAPEUTICS
- Publication
Nature Medicine, 2014, Vol 20, Issue 12, p1370
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm1214-1370